Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ruitao Lu
Enhancement of Oncolytic Activity of oHSV Expressing IL-12 and Anti PD-1 Antibody by Concurrent Administration of Exosomes Carrying CTLA-4 miRNA
Related publications
Effect of in Vivo Administration of Anti-Ctla-4 Monoclonal Antibody and IL-12 on the Induction of Low-Dose Oral Tolerance
Clinical and Experimental Immunology
Allergy
Immunology
Intestinal Microbiota Predict Response and Toxicities During Anti-Pd-1/Anti-Ctla-4 Immunotherapy
Pathology
Forensic Medicine
Pathology
CTLA4 Methylation Predicts Response to Anti–PD-1 and Anti–CTLA-4 Immunotherapy in Melanoma Patients
JCI insight
Medicine
Comment on ‘Efficacy and Toxicity of Treatment With the Anti-Ctla-4 Antibody Ipilimumab in Patients With Metastatic Melanoma After Prior Anti-Pd-1 Therapy’
British Journal of Cancer
Cancer Research
Oncology
The Safety and Tolerability of Combined Immune Checkpoint Inhibitors (Anti-Pd-1/Pd-L1 Plus Anti-Ctla-4): A Systematic Review and Meta-Analysis
BMC Cancer
Cancer Research
Oncology
Genetics
Enhancement of Anti-Tumor Immunity Through Local Modulation of CTLA-4 and GITR by Dendritic Cells
European Journal of Immunology
Allergy
Immunology
Ipilimumab: An Anti-Ctla-4 Antibody for Metastatic Melanoma
Clinical Cancer Research
Cancer Research
Oncology
P105 Computational Design of IgG-like Tetra-Specific Antibody Targeting EGFR/VEGF/PD-1/CTLA-4 Against NSCLC
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Interdependent IL-7 and IFN-γ Signalling in T-Cell Controls Tumour Eradication by Combined Α-Ctla-4+α-Pd-1 Therapy
Nature Communications
Astronomy
Genetics
Molecular Biology
Biochemistry
Chemistry
Physics
